DK143095C - Fremgangsmaade til fremstilling af faste laegemidler,indeholdende substituerede xanthiner,med forlaenget afgivelse af terapeutisk virksomme forbindelser - Google Patents

Fremgangsmaade til fremstilling af faste laegemidler,indeholdende substituerede xanthiner,med forlaenget afgivelse af terapeutisk virksomme forbindelser

Info

Publication number
DK143095C
DK143095C DK612568A DK612568A DK143095C DK 143095 C DK143095 C DK 143095C DK 612568 A DK612568 A DK 612568A DK 612568 A DK612568 A DK 612568A DK 143095 C DK143095 C DK 143095C
Authority
DK
Denmark
Prior art keywords
medicinals
procedure
preparation
solid
therapeutically effective
Prior art date
Application number
DK612568A
Other languages
English (en)
Other versions
DK143095B (da
Inventor
M Reiser
E Eidebenz
L Nook
Original Assignee
Hoechst Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hoechst Ag filed Critical Hoechst Ag
Publication of DK143095B publication Critical patent/DK143095B/da
Application granted granted Critical
Publication of DK143095C publication Critical patent/DK143095C/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/519—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
    • A61K31/525—Isoalloxazines, e.g. riboflavins, vitamin B2
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/519—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
    • A61K31/52—Purines, e.g. adenine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/59—Compounds containing 9, 10- seco- cyclopenta[a]hydrophenanthrene ring systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605—Excipients; Inactive ingredients
    • A61K9/1617—Organic compounds, e.g. phospholipids, fats

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biophysics (AREA)
  • Molecular Biology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
DK612568A 1967-12-16 1968-12-13 Fremgangsmaade til fremstilling af faste laegemidler,indeholdende substituerede xanthiner,med forlaenget afgivelse af terapeutisk virksomme forbindelser DK143095C (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE1967C0044173 DE1617418C3 (de) 1967-12-16 1967-12-16 Herstellung von festen Arzneimittelformen mit verzögerter Wirkstoffabgabe
DEC0044173 1967-12-16

Publications (2)

Publication Number Publication Date
DK143095B DK143095B (da) 1981-03-30
DK143095C true DK143095C (da) 1981-10-05

Family

ID=7025697

Family Applications (1)

Application Number Title Priority Date Filing Date
DK612568A DK143095C (da) 1967-12-16 1968-12-13 Fremgangsmaade til fremstilling af faste laegemidler,indeholdende substituerede xanthiner,med forlaenget afgivelse af terapeutisk virksomme forbindelser

Country Status (4)

Country Link
AT (1) AT301759B (da)
DE (1) DE1617418C3 (da)
DK (1) DK143095C (da)
FR (1) FR8339M (da)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2520978C3 (de) * 1975-05-10 1981-02-19 Hoechst Ag, 6000 Frankfurt Dosierungseinheit einer festen, oral zu verabreichenden Arzneiform von wasserlöslichen Xanthin-Derivaten
DE3024416C2 (de) * 1980-06-28 1982-04-15 Gödecke AG, 1000 Berlin Verfahren zur Herstellung von Arzneimitteln mit retardierter Wirkstoff-Freisetzung
US4612194A (en) * 1984-02-15 1986-09-16 Roshdy Ismail Anti-rheumatic agents and their use
MA23587A1 (fr) * 1994-06-23 1995-12-31 Procter & Gamble Traitement du besoin en nicotine et/ou du syndrome de manque lie au tabagisme

Also Published As

Publication number Publication date
DE1617418B2 (de) 1974-08-29
AT301759B (de) 1972-08-15
DK143095B (da) 1981-03-30
DE1617418A1 (de) 1971-03-25
FR8339M (da) 1970-12-14
DE1617418C3 (de) 1980-01-24

Similar Documents

Publication Publication Date Title
SE382065B (sv) Forfarande for framstellning av linkomycinderivat
DK131628C (da) Fremgangsmade til fremstilling af tioninderivater
DK118820B (da) Analogifremgangsmåde til fremstilling af derivater af 5-nitro-2-furyl-isoxazoliner.
DK123482B (da) Analogifremgangsmåde til fremstilling af alkaloider.
DK125850B (da) Analogifremgangsmåde til fremstilling af heterocykliske forbindelser.
DK560675A (da) Fremgangsmade til fremstilling af thiopyrimidinderivater
DK125707B (da) Fremgangsmåde til fremstilling af tricycliske forbindelser.
DK134911B (da) Fremgangsmåde til fremstilling af 3-formylrifamycin SV-derivater.
DK143095C (da) Fremgangsmaade til fremstilling af faste laegemidler,indeholdende substituerede xanthiner,med forlaenget afgivelse af terapeutisk virksomme forbindelser
DK123868B (da) Analogifremgangsmåde til fremstilling af 3-hydroxycumarin-derivater.
DK114697B (da) Fremgangsmåde til fremstilling af 25-desacetylderivater af rifamyciner.
DK122041B (da) Analogifremgangsmåde til fremstilling af substituerede tetrazoler.
DK124214B (da) Fremgangsmåde til fremstilling af pyrrolnitrinderivater.
DK118507B (da) Fremgangsmåde til fremstilling af 3-dimethylsulfamoylphenthiazinderivater.
DK119663B (da) Analogifremgangsmåde til fremstilling af 2-benzolsulfonamidopyrimidinforbindelser.
DK133107C (da) Fremgangsmade til fremstilling af penicillinestere eller penicillinsulfoxidestere
DK132586C (da) Fremgangsmade til fremstilling af erythromycylaminer
DK131786C (da) Fremgangsmade til fremstilling af delta4-3-oxo-1alfa-methylsteroider
DK118251B (da) Analogifremgangsmåde til fremstilling af derivater af tropin- eller pseudotropinestere.
DK132631C (da) Fremgangsmade til fremstilling af semisyntetiske penicilliner
DK133373B (da) Analogifremgangsmåde til fremstilling af 2-phenyl-cyclohexen-3-carboxylsyre-derivater.
SE343302B (sv) Foerfarande foer framstaellning av bensomorfanderivat
DK139577B (da) Fr&mgangsmaade til fremstilling af desphenylalaninb1-insulin
DK103681A (da) Fremgangsmaade til fremstilling af 7-aminocephalosporansyre
DK132625C (da) Fremgangsmade til fremstilling af rifamycinderivater